I do not know what percentage, but short squeezes can generate multiples in share price appreciation. In the previously mentioned Jagnotes example the share price increased by a factor of 8. Volkswagon is another example.
Exactly, and that wait will come at a SUBSTANTIAL cost to us retail shareholders. Why? Because Star will probably have to issue more shares before we become cashflow positive. That is particularly so if we are embarking on a "dual-track" strategy as was mentioned in the PR. That IND effort with the FDA will cost money. And as I said previously, at $2 per share you must issue 5 million shares to get $10 million; at $10 per share you only need to issue 1 million shares. It is in our best interest as shareholders for the company to address this "short" problem sooner, rather than later.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.